197 filings
Page 4 of 10
SC 13G
Infini Master Fund
13 Jun 22
I-Mab / Infini Master Fund ownership change
10:44am
6-K
IMAB
I-Mab
27 May 22
I-Mab Reports Latest Phase 2 Clinical Data of its Differentiated CD73 Antibody Uliledlimab
6:02am
6-K
IMAB
I-Mab
18 May 22
Current report (foreign)
6:34am
6-K
IMAB
I-Mab
5 May 22
I-Mab Provides Updates on Status under Holding Foreign Companies Accountable Act
12:00am
20-F
2021 FY
IMAB
I-Mab
Annual report (foreign)
29 Apr 22
4:06pm
6-K/A
IMAB
I-Mab
28 Apr 22
Financial results demonstrate strong fundamentals
4:53pm
6-K
IMAB
I-Mab
28 Apr 22
I-Mab Announces Appointments of Richard Yeh as Chief Operating Officer and John Hayslip as Chief Medical Officer
9:26am
6-K
IMAB
I-Mab
31 Mar 22
I-Mab Announces Voluntary Lock-ups by Key Shareholders and Senior Management for Long-Term Commitment
4:46pm
6-K/A
IMAB
I-Mab
31 Mar 22
Financial results demonstrate strong fundamentals
4:45pm
424B3
IMAB
I-Mab
31 Mar 22
Prospectus supplement
4:44pm
6-K
IMAB
I-Mab
29 Mar 22
Financial results demonstrate strong fundamentals
9:26am
6-K
IMAB
I-Mab
4 Mar 22
I-Mab Receives FDA Orphan Drug Designation for its Novel Claudin 18.2 x 4-1BB Bispecific
6:11am
6-K
IMAB
I-Mab
22 Feb 22
Current report (foreign)
4:04pm
SC 13G/A
GIC Private Ltd
14 Feb 22
I-Mab / GIC Private ownership change
9:10am
SC 13G
IMAB
I-Mab
14 Feb 22
I-Mab / PRICE T ROWE ASSOCIATES ownership change
2:34pm
SC 13G/A
Jingwu Zhang Zang
11 Feb 22
I-Mab / Zang Jingwu Zhang ownership change
4:02pm
6-K
IMAB
I-Mab
28 Jan 22
I-Mab’s Announcement on Unusual Price Movement
7:23am
SC 13G/A
CBC Investment I-Mab Ltd
25 Jan 22
I-Mab / CBC Investment I-Mab ownership change
6:40am
424B3
IMAB
I-Mab
14 Jan 22
Prospectus supplement
4:02pm
6-K
IMAB
I-Mab
21 Dec 21
I-Mab Strengthens Management Team Designed to Accelerate Global Pipeline Development and Transformation Towards Commercialization
6:05am